We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
Cap. Flow
+$2.23B
Cap. Flow %
1.36%
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Financials 8.92%
3 Healthcare 7.98%
4 Industrials 6.57%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHOE
3576
Shoe Station Group
SHOE
$431M
$222K ﹤0.01%
+5,065
New +$207K
QVCGA
3577
DELISTED
QVC Group Inc Series A
QVCGA
$222K ﹤0.01%
7,277
-18
-0.2% -$571
IGRO icon
3578
iShares International Dividend Growth ETF
IGRO
$1.29B
$222K ﹤0.01%
2,975
-1,312
-31% -$93K
RZV icon
3579
Invesco S&P SmallCap 600 Pure Value ETF
RZV
$296M
$222K ﹤0.01%
+2,028
New +$214K
BTAL icon
3580
AGF US Market Neutral Anti-Beta Fund
BTAL
$307M
$221K ﹤0.01%
+11,267
New +$224K
FLN icon
3581
First Trust Latin America AlphaDEX Fund
FLN
$37.4M
$221K ﹤0.01%
12,231
-11,706
-49% -$213K
MFA
3582
MFA Financial
MFA
$935M
$220K ﹤0.01%
17,324
+19
+0.1% +$224
WNS
3583
DELISTED
WNS Holdings
WNS
$220K ﹤0.01%
4,175
-6,477
-61% -$367K
BORR
3584
Borr Drilling
BORR
$1.2B
$220K ﹤0.01%
+40,000
New +$245K
HPF
3585
John Hancock Preferred Income Fund II
HPF
$342M
$220K ﹤0.01%
11,774
-1,308
-10% -$22.3K
JACK icon
3586
Jack in the Box
JACK
$308M
$219K ﹤0.01%
4,716
-48
-1% -$2.41K
LLY icon
3587
PUT
Eli Lilly
LLY
$1.09T
$219K ﹤0.01%
+300
New +$270K
TIPT icon
3588
Tiptree Inc
TIPT
$678M
$218K ﹤0.01%
+11,155
New +$207K
EVER icon
3589
EverQuote
EVER
$960M
$218K ﹤0.01%
10,349
-31,411
-75% -$718K
VTS icon
3590
Vitesse Energy
VTS
$626M
$218K ﹤0.01%
+9,083
New +$224K
PFS icon
3591
Provident Financial Services
PFS
$3.15B
$218K ﹤0.01%
11,730
-1,000
-8% -$17.7K
SPXL icon
3592
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.57B
$217K ﹤0.01%
+1,326
New +$198K
ACAD icon
3593
Acadia Pharmaceuticals
ACAD
$4.45B
$217K ﹤0.01%
14,119
-333
-2% -$5.55K
BIBL icon
3594
Inspire 100 ETF
BIBL
$487M
$217K ﹤0.01%
5,335
+2
+0% +$78
CYTK icon
3595
Cytokinetics
CYTK
$10.8B
$217K ﹤0.01%
4,107
+234
+6% +$13K
EPU icon
3596
iShares MSCI Peru and Global Exposure ETF
EPU
$530M
$217K ﹤0.01%
5,016
-6,125
-55% -$249K
PVAL icon
3597
Putnam Focused Large Cap Value ETF
PVAL
$13B
$216K ﹤0.01%
5,692
CRDO icon
3598
Credo Technology Group
CRDO
$35.9B
$215K ﹤0.01%
6,996
-8,331
-54% -$248K
DNOV icon
3599
FT Vest US Equity Deep Buffer ETF November
DNOV
$395M
$215K ﹤0.01%
5,103
-2,385
-32% -$99.6K
PTIN icon
3600
Pacer Trendpilot International ETF
PTIN
$180M
$215K ﹤0.01%
6,952
-4,817
-41% -$143K

Similar funds

Raymond James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
  • Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
  • Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
  • Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
  • Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
  • Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
  • Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.